Literature DB >> 8044037

ECT as a treatment for depression in Huntington's disease.

N G Ranen1, C E Peyser, S E Folstein.   

Abstract

The authors review the records of 6 patients with Huntington's disease (HD) who received electroconvulsive therapy (ECT) for depression. Five patients met criteria for major depression and 1 for bipolar disorder, depressed. None of the patients had responded to pharmacologic intervention, and 5 improved after ECT treatment. The 2 patients who had prominent delusions showed the greatest improvement. Apathy, and to some extent irritability, responded less well. One patient developed delirium, and the movement disorder worsened in another patient. ECT should be a treatment option in the management of depression in Huntington's disease, particularly when depression is resistant to pharmacologic treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8044037     DOI: 10.1176/jnp.6.2.154

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  11 in total

1.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

2.  Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease.

Authors:  Hesitha Abeysundera; Allan Campbell; Shanthi Sarma
Journal:  BMJ Case Rep       Date:  2019-08-10

Review 3.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 4.  Huntington's Disease-Update on Treatments.

Authors:  Kara J Wyant; Andrew J Ridder; Praveen Dayalu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

5.  Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

Authors:  Mohamed R Mughal; Akanksha Baharani; Srinivasulu Chigurupati; Tae Gen Son; Edmund Chen; Peter Yang; Eitan Okun; Thiruma Arumugam; Sic L Chan; Mark P Mattson
Journal:  Hum Mol Genet       Date:  2010-11-24       Impact factor: 6.150

6.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

Review 7.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

8.  Ect in neurological counditions.

Authors:  K Girish; B N Gangadhar; N Janakiramaiah
Journal:  Indian J Psychiatry       Date:  2002-07       Impact factor: 1.759

Review 9.  Neuropsychiatry of Huntington's disease.

Authors:  Adam Rosenblatt
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

10.  Electroconvulsive therapy for severe depression, psychosis and chorea in a patient with Huntington's disease: case report and review of the literature.

Authors:  Walied Mowafi; Jon Millard
Journal:  BJPsych Bull       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.